Associations of methadone and buprenorphine-naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription-type opioid use disorders: Exploratory analyses of the OPTIMA study.
Hamzah BakouniChristina McAnultyOvidiu TatarM Eugenia SociasBernard Le FollRon LimKeith AhamadDidier Jutras-Aswadnull nullPublished in: The American journal on addictions (2023)
Our results extend previous findings of high doses of methadone increasing retention to be applied in our population using opioids other than heroin, including highly potent opioids.